Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Human Abuse Potential: Subjective Ratings
Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
Insights From The EACT Clinical Trials Site Personnel Webinar
Collaboration among clinical research stakeholders is breaking financial barriers to support equitable trial access.
Change Needed In Approach To Clinical Trials Patient Recruitment
Drawing on real-world experience and end-to-end capabilities, this presentation outlines actionable strategies to accelerate recruitment, boost predictability, and expand patient trial access.
Planning For Clinical Trial Chaos
Clinical study management has fundamentally changed. This video explores why the traditional top-heavy approach must give way to more efficient, adaptable products.

Beyond Go-Live: The True RTSM Quality Test
3/25/2026

Go‑live is only the beginning. This clip highlights how RTSM performance evolves over years of real‑world use — and why long‑term flexibility is just as important as a clean launch.
RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters
2/25/2026

Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.
From Chaos To Clarity: A Founder's View From 30 Years In Drug Development
7/16/2026

Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.
De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital
9/3/2025

For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
Protocol Flexibility Is A Quality Strategy
5/27/2026

Anna-Zeralda Canals Hamann shares how flexible IRT design can help sponsors prepare for changes in supply strategy, dosing, and patient cohorts. Effective RTSM systems are designed to manage uncertainty without disrupting trial operations.

The Problem-Solving, Patient Advocate Team That Every Trial Needs

Patient Kindness is a supplemental layer of premium support that offers a more seamless clinical trial experience for patients and caregivers with more complex or nuanced needs.
Decentralized Trials Support: Direct-To-Patient Supply Management

Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
User Acceptance Testing (UAT): Keeping Trials On Track

Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.
Accelerate Enrollment And Reduce Site Burden

Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.
PULSE: Empowering Every Phase of Your Clinical Journey

A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.